Phosplatin Therapeutics Appoints Lorenzo Galluzzi, PhD, a Pi

Phosplatin Therapeutics Appoints Lorenzo Galluzzi, PhD, a Pioneer in Immunogenic Cell Death Research, to Scientific Advisory Board - read this article along with other careers information, tips and advice on BioSpace

Related Keywords

United States , China , Germany , New York , Canada , Paris , France General , France , Robert Fallon , Mark Corbae , Stephanie Carrington , Weil Cornell , Taylorb Young , Lorenzo Galluzzi , Gustave Roussy Comprehensive Cancer Center , Weill Cornell Medical College , Merck Kga , Galluzzi Lab , Lab Times , European Academy For Tumor Immunology , University Paris Sud , Strategic Development , Galluzzi Lab At Weill Cornell Medical College , Phosplatin Therapeutics Inc , European Research Institute For Integrated Cellular Pathology , Weill Cornell Medical College Galluzzi Lab , Merck Kgaa , Serono , Department Of Dermatology , Cornell Medical College , Scientific Advisory , Phosplatin President , Chief Executive Officer Robert , Scientific Advisory Board , Assistant Professor , Cell Biology , Radiation Oncology , Yale School , Assistant Professor Adjunct , European Academy , Tumor Immunology , European Research Institute , Integrated Cellular , Highly Cited Researcher , Clarivate Analytics , University Paris , Phosplatin Therapeutics , Resume , Careers , Hosplatin Therapeutics Appoints Lorenzo Galluzzi , Phd , A Pioneer In Immunogenic Cell Death Research , O Scientific Advisory Board , Iospace , Advice ,